Defense Production and Active Pharmaceutical Ingredients Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 6895.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. SLOTKIN, as printed in the Congressional Record (Vol. 169, No. 211, December 22, 2023, Page H7008):
  Article 1, Section 8, Clause 18: To make all Laws which shall be necessary and proper for carrying into Execution the foregoing Powers, and all other Powers vested by this Constitution in the Government of the United States, or in any Department or Office thereof. The single subject of this legislation is: To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.
  Source: Congress.gov, Congressional Record December 22, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  524 characters

  Congress.gov bill record

  H.R. 6895, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/6895

  Record last updated by Congress.gov

  June 6, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  db66e9c49cec2b2b439c6f21c957e5a75494628791abbebf2f616850705e0fa8

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of June 6, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 6895, last updated June 6, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.